You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsed / refractory AML

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

Recruiting
  • Core Binding Factor Acute Myeloid Leukemia
  • KIT Mutation-Related Tumors
  • Suzhou, Jiangsu, China
    First Affiliated Hospital of Soochow University
Apr 7, 2023

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
  • Hefei, Anhui, China
  • +7 more
Jun 27, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti-siglec-6 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 2, 2022

AML, AML, Adult Trial in Indianapolis (TAK-659, Ixazomib)

Terminated
  • AML
  • AML, Adult
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Cancer Center
Mar 15, 2022

Acute Myeloid Leukemia Trial in Hanzhou (Clifutinib Besylate)

Recruiting
  • Acute Myeloid Leukemia
  • Clifutinib Besylate
  • Hanzhou, China
    the First Affiliated Hospital,College of Medicine,Zhejiang Unive
Aug 10, 2022

Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and

Recruiting
  • Leukemia, Myeloid, Acute
  • +2 more
  • venetoclax combining chidamide and azacitidine (VCA)
  • Xiamen, Fujian, China
    Bing Xu
Aug 1, 2022

Acute Myeloid Leukemia Trial (TCB008)

Recruiting
  • Acute Myeloid Leukemia
  • Bristol, United Kingdom
  • +5 more
Jan 10, 2023

Acute Myeloid Leukemia Trial (WU-NK-101)

Not yet recruiting
  • Acute Myeloid Leukemia
  • WU-NK-101
  • (no location specified)
Jul 20, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome
  • ASP7517
  • Duarte, California
  • +15 more
Jan 19, 2023

AML, MDS Trial in Tianjin (XZB-0004)

Not yet recruiting
  • AML
  • MDS
  • Tianjin, Tianjin, China
    Hematology Hospital, Chinese Academy of Medical Sciences
Feb 13, 2023

MDS, Acute Myeloid Leukemia Trial in France (BST-236)

Recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • Amiens, France
  • +16 more
Jan 2, 2023

AML Trial in Wuhan (CAR--?dT cells)

Recruiting
  • AML
  • CAR--γδT cells
  • Wuhan, Hubei, China
    Tongji Hospital
May 24, 2022

Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123

Recruiting
  • Leukemia
  • +3 more
  • MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
  • Amsterdam, Netherlands
  • +4 more
Jan 4, 2023

Acute Myeloid Leukaemia Trial (SAR445419, fludarabine, cytarabine)

Not yet recruiting
  • Acute Myeloid Leukaemia
  • (no location specified)
Feb 2, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Trial in Zhengzhou (6MW3211

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • 6MW3211 injection with Intravenous Infusion
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 2, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Seattle (SC-DARIC33)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • SC-DARIC33
  • Seattle, Washington
    Seattle Children's Hospital
Sep 6, 2022

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

Suspended
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Tampa, Florida
    Moffitt Cancer Center
Nov 11, 2022

Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia Trial in Saint Louis (biological, drug, procedure)

Not yet recruiting
  • Refractory Acute Myeloid Leukemia
  • Relapsed Acute Myeloid Leukemia
  • Cytokine induced memory-like NK cells
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 30, 2022

Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

Recruiting
  • Acute Myeloid Leukemia
  • allogenic NK cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Acute Myeloid Leukemia Trial in Columbus (Universal Donor Natural Killer Cells)

Recruiting
  • Acute Myeloid Leukemia
  • Universal Donor Natural Killer Cells
  • Columbus, Ohio
    Nationwide Children's Hospital
Aug 11, 2022

Relapsed/Refractory Acute Myeloid Leukemia Trial (LILRB4 STAR-T cells)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • LILRB4 STAR-T cells
  • (no location specified)
Sep 16, 2022

Acute Myeloid Leukemia, Relapsed AML, Refractory AML Trial in Germany (GEM333)

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Mannheim, Baden-Württemberg, Germany
  • +6 more
Sep 28, 2022

Acute Myeloid Leukemia Trial in Baltimore, Chapel Hill, Charleston (pembrolizumab, Azacitadine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
  • +2 more
May 19, 2022